We evaluated a large multicenter series of patients operated on for low-flow/low-gradient aortic stenosis (LF/ LGAS) to stratify the operative risk, assess whether perioperative mortality has decreased over recent years, and analyze the post-operative outcome.
Patients with severe aortic stenosis (AS) and reduced left ventricular ejection fraction (LVEF) have a poor prognosis with conservative treatment. In addition, aortic valve replacement (AVR) in these patients is associated with a relatively high operative mortality (1, 2) . Operative risk is particularly high in patients with low pre-operative transvalvular mean gradient (MG) (3) . Although American College of Cardiology/American Heart Association guidelines recently defined low-gradient AS as severe AS with an MG Յ30 mm Hg, low flow, and left ventricular dysfunction (4) , the definition of "low-gradient" AS has varied from study to study (5) . Few data are available concerning the results of surgery in patients with severe AS and a MG Յ30 mm Hg (3, 6, 7) . Most published studies (5,8 -10) have included patients with mean aortic transvalvular gradient between 30 and 40 mm Hg, who are known to be at lower operative risk (5) . We therefore evaluated a large series of consecutive patients operated for AS with low gradient (Յ30 mm Hg) to stratify the operative risk, assess whether the perioperative mortality decreased over the recent period, analyze the post-operative outcome, and determine the predictors of long-term mortality.
Methods
The study population consisted of 217 consecutive patients, 168 men (77%) and 49 women (23%), with symptomatic severe aortic stenosis (area Ͻ1 cm 2 ), low ejection fraction (EF) (Յ35%), and low MG (Յ30 mm Hg) who underwent aortic valve replacement between 1990 and 2005. Eleven centers were involved in this European study (Amiens, France; Bergamo, Italy; Bordeaux, France; Brest, France; Brussels, Belgium; Créteil, France; Lille, France; Rennes, France; Rouen, France; Saint Denis, France; and Strasbourg, France). Patients with significant aortic regurgitation, severe mitral regurgitation, or associated mitral surgery were excluded. Clinical, laboratory, and echocardiographic data are presented in Table 1 . Pre-operative atrial fibrillation was defined as permanent or paroxystic atrial fibrillation before surgery. Patients with unstable hemodynamic status operated during the 4 days following admission were considered emergency cases. Clinical follow-up was completed in all patients, with a mean follow-up of 31 Ϯ 21 months. Echocardiography. Complete pre-operative echocardiography, including aortic valve area assessment, was performed in all patients (11) . Left ventricular ejection fraction was estimated according to Simpson's rule (12) in 86% of patients and visually (13) in 14% of patients. Dobutamine stress echocardiography (DSE) was performed in 38% of patients (83 of 217) according to a previously described standard protocol (9, 10) . Contractile reserve was defined by an increase in stroke volume of Ն20% compared with the baseline value (9, 10, 14) . All patients with contractile reserve had fixed AS, defined as an increase in valve area Ͻ0.3 cm 2 with a final valve area Յ1 cm 2 on DSE (9, 10, 14) . Use of DSE for each patient was left to the discretion of the referring physicians in each center. Coronary angiography. Pre-operative coronary angiography was performed in 98% of patients. Reduction of the normal diameter Ն50% was considered to define significant coronary artery stenosis in the left main coronary artery. A cutoff value of 70% was used for the right coronary, left anterior descending, and circumflex arteries. Multivessel coronary artery disease (MVD) was defined as significant stenoses on 2 or more vessels. Calculation of the European System for Cardiac Operative Risk Evaluation (EuroSCORE). The standard Euro-SCORE was calculated retrospectively for each patient using the calculator available online (15) . Integrated risk factors in the EuroSCORE are patient-related, cardiac, and operation-related factors. Patient-related factors are age over 60 years, female gender, chronic pulmonary disease, extracardiac arterial disease, neurologic dysfunction, previous cardiac surgery, serum creatinine Ͼ200 mol/l, active endocarditis, and critical pre-operative state. Cardiac factors are unstable angina, reduced LVEF, recent myocardial infarction, and pulmonary systolic pressure Ͼ60 mm Hg. Operation-related factors are emergency, other than isolated coronary surgery; thoracic aorta surgery; and surgery for post-infarct septal rupture. Mortality and clinical followup. Operative mortality was defined as death within 30 days after AVR (3, 10) . Overall mortality combined operative mortality and late mortality. The end points evaluated at follow-up were survival and New York Heart Association (NYHA) functional status. The NYHA functional status after surgery, obtained by direct patient examination or telephone interview, was available in 85% (156 of 183) of the patients who survived after AVR. Ejection fraction after AVR was evaluated by the referring physician and was available in 76% of the surviving patients after AVR. Statistical analysis. Continuous variables are expressed as mean Ϯ SD, and categorical variables are expressed as percentages. Comparisons between groups were performed using the chi-square test or the Fisher exact test (when needed) to analyze differences in categorical variables. The Student t test or Wilcoxon rank-sum test were used as appropriate for continuous variables. Changes in NYHA functional status over time were compared using the McNemar's test. The optimal cutoff value of EuroSCORE to predict operative mortality was determined by receiveroperating characteristic curve analysis. On multivariate analysis, the Cox proportional hazard model was used to study survival after AVR, and logistic regression was used to analyze operative mortality. All multivariate analyses were performed with p Ͻ 0.05 as the limit on univariate analysis for entering or removing variables. Survival curves were plotted using the Kaplan-Meier method and differences were tested with the log-rank test. A p value Ͻ0.05 was considered statistically significant.
Results
Pre-operative clinical, echocardiographic, and angiographic data from the 217 patients of the study are presented in Table 1 . Pre-operatively, 79% (123 of 156) of patients were Levy et al. April 15, 2008 April 15, :1466 Prognosis in Low-Gradient AS classified as NYHA functional class III or IV, compared with 16% (25 of 156) after AVR (p ϭ 0.0001). The LVEF significantly improved from 28 Ϯ 5% pre-operatively to 41 Ϯ 13% after AVR (p ϭ 0.0001). Operative mortality. In the overall series, perioperative mortality was 16% (n ϭ 34), related to cardiogenic shock in 79% (n ϭ 27), septic shock in 9% (n ϭ 3), stroke in 3% (n ϭ 1), respiratory failure in 3% (n ϭ 1), multiorgan failure in 3% (n ϭ 1), and critical limb ischemia in 3% (n ϭ 1). Longer cardiopulmonary bypass time and cross-clamp time were also associated with perioperative mortality. On univariate analysis, higher EuroSCORE, very low MG and EF, NYHA functional class III or IV, history of congestive heart failure, and MVD were associated with perioperative mortality (Table 1) . These parameters were entered in the multivariate model for perioperative mortality. and MVD (OR 6; 95% CI 1.5 to 24; p ϭ 0.01) as independent predictors of perioperative mortality. Patients who had DSE were more frequently women (32% vs. 16%; p ϭ 0.006), had a lower rate of paroxysmal or permanent atrial fibrillation (18% vs. 32%; p ϭ 0.023), had lower pre-operative EF (26 Ϯ 6 vs. 29 Ϯ 6; p ϭ 0.002), and were less often operated in emergency (6% vs. 16%; p ϭ 0.024).
Baseline characteristics of patients operated in the 1990 to 1999 era (n ϭ 112) and in the 2000 to 2005 era (n ϭ 105) are summarized in Table 2 . Operative mortality was lower in the recent era (10% vs. 20%, p ϭ 0.04). No significant differences were observed between the 2 groups for most pre-operative parameters. However, in the recent era, emergency AVR was more frequent (p ϭ 0.04), prior myocardial infarction and atrial fibrillation tended to be more frequent, and cardiopulmonary bypass time tended to be shorter. Perioperative deaths related to cardiogenic shock were more frequent in the past era than in the current era (91% vs. 54%, p ϭ 0.024).
Survival after AVR.
The overall 5-year survival rate in the total population was 49 Ϯ 4% (Fig. 1) . On univariate analysis, overall survival was significantly lower in patients with higher EuroSCORE, diabetes, prior AF, pre-operative MG Յ20 mm Hg, and MVD ( 
Discussion
Operative risk in severe AS associated with LV dysfunction is known to be increased, particularly when mean transvalvular gradient is low. This retrospective multicenter study, the largest on low-flow/low-gradient AS (LF/LGAS) to our knowledge, shows that operative mortality decreased from 20% to 10% over recent years. The presence of multivessel CAD, MG, and DSE results were identified as independent pre-operative predictors of perioperative mortality. Moreover, we found that pre-operative standard EuroSCORE was a useful tool for operative risk stratification. Long-term survival continued to be influenced by pre-operative MG, EuroSCORE, associated MVD, and atrial fibrillation. Perioperative mortality (16%) in our series can be considered to be acceptable, as rates ranging from 11% to 21% have been reported in previous studies on patients with LF/LGAS (3, 8) . Pereira et al. (7) recently reported a lower operative mortality of 6% in a series of 68 patients. Systematic echocardiography in the setting of congestive heart failure might bring earlier diagnosis of significant AS before patients go into cardiogenic shock. Our study shows that operative mortality decreased dramatically from 20% to 10% in the recent era. This may be related to recent progress in cardiac surgery and perioperative care, leading to a lower incidence of left ventricular failure during the perioperative period. Moreover, the prevalence of cardiogenic shock as a cause of death was lower in the more recent period of our study. Perioperative risk can be clearly stratified. In our study, a EuroSCORE Ͼ10 identified a high-risk population of patients with a perioperative mortality of 25%, compared with 12% for a EuroSCORE Յ10. Connolly et al. (3) identified small prosthesis size as the only predictor of hospital mortality. In our study, we found that lower MG and presence of MVD were strong independent predictors of perioperative mortality. Moreover, Connolly et al. (3) reported a trend toward lower overall 5-year survival in patients with associated CAD compared to patients without CAD in a series of 52 patients. Our larger study demonstrated the major influence of MVD on operative mortality and long-term overall survival. Thus, in our series, the 5-year survival rate was 37% in patients with associated MVD, compared with 55% in patients without associated MVD (p ϭ 0.02). Similarly, dobutamine stress hemodynamic results are a strong predictor of perioperative mortality in low-flow and very low-gradient AS (10) . Preoperative atrial fibrillation was found to influence overall survival, reflecting long-standing disease, which may be associated with more severe disease (16) . In contrast, neither prior myocardial infarction nor small prosthesis size, as previously reported by others (3, 17) , were predictors of perioperative mortality in this study.
An improvement of functional class is frequently observed after AVR: 88% of patients in the series by Connolly et al. (2) and 76% of our patients improved their NYHA functional class by more than 1 class. As previously described (2, 3, 7, 18) , EF significantly improved after AVR owing to afterload mismatch correction (19) . The 49% 5-year survival after AVR in our series was relatively high, compared with the 40% survival reported by Connolly et al. (3), including patients with a higher prevalence of CAD. More than one-half of late deaths in the present study were due to noncardiac causes. Thus, in LF/LGAS, significant CAD and very low MG (Յ20 mm Hg) are 2 major risk factors influencing both perioperative and long-term outcome. Study limitations. This study was retrospective, but it included consecutive patients operated for LF/LGAS, according to the definition of American College of Cardiology/American Heart Association guidelines, in 11 European centers. The strength of this study is the large number of patients included in different centers, giving statistical power and avoiding single-center biases. No larger series of this type of patient has been published to date. Multivariate analyses in our study evaluated a relatively large number of potential predictors relative to the number of events. In view of the long inclusion period and the large number of centers, only 38% of patients in the study had DSE. As previously reported (9, 10) , the strong prognostic value of contractile reserve to assess the operative risk was demonstrated in this subgroup of patients. A more frequent use of DSE to stratify operative risk over recent years in our study might have been an explanation for the decrease in operative mortality in the recent period. However, the percentage of patients who had DSE was not significantly different during the 2 periods (35% in the 1990 to 1999 period vs. 41% in the 2000 to 2005 period; p ϭ 0.38), similar to the proportion of patients without contractile reserve during DSE (11% in the 1990 to 1999 period vs. 10% in the 2000 to 2005 period; p ϭ 0.48). We cannot assess in our series the prognosis of "pseudosevere AS," in which increase of transvalvular flow results in an increase in valve area to a nonsevere range (5), as patients who had this response to DSE were not referred for surgery in the different participating centers. However, we cannot exclude the probability that some patients of our series may not have had critical AS. Pre-operative NYHA functional status in our study was evaluated under optimal medical treatment. Seventeen percent (n ϭ 37) of our patients were in pre-operative NYHA functional class II (no patients were in class I). Actually, pre-operative NYHA functional status was evaluated under optimal medical treatment (at least diuretics), and 90% of these 37 patients in pre-operative NYHA functional class II had a recent history of congestive heart failure. The prevalence of preoperative NYHA functional classes I and II was 35% in the series reported by Pereira et al. (7) and 15% in the series of Levy et al. April 15, 2008 April 15, :1466 Prognosis in Low-Gradient AS
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